Literature DB >> 23808468

Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.

Deepali Jain1, Nabeen C Nayak, Vinay Kumaran, Sanjiv Saigal.   

Abstract

CONTEXT: The common risk factors for hepatocellular carcinoma (HCC) include persistent viral infection with either hepatitis B or C virus, alcohol abuse, hemochromatosis, and metabolic syndrome. Steatohepatitic (SH) HCC has been recently recognized as a special morphologic variant of HCC associated with metabolic risk factors.
OBJECTIVE: To assess the SH pattern in HCC cases of various etiologies in Indian patients and to further correlate this morphology with the presence of metabolic risk factors.
DESIGN: A total of 101 cases of HCC with various etiologies in explanted livers from adults were included in the study. Morphologic examination was performed to identify SH lesions within the tumor and in the nontumorous liver parenchyma. Correlation of nontumor and tumor SH morphology with clinically identifiable metabolic risk factors and with non-SH type of HCC was performed.
RESULTS: The SH variant of HCC was identified in 19 livers (18.8%). Most SH-HCC cases were associated with metabolic risk factors such as obesity, diabetes, hypertension, and hyperlipidemias. Comparison of SH-HCC with non-SH-HCC was statistically significant in terms of presence of metabolic risk factors.
CONCLUSIONS: Steatohepatitic morphology in HCC is frequent in nonalcoholic fatty liver disease-associated cirrhosis (P = .009) and is significantly associated with metabolic risk factors (P = .03). By recognizing SH pattern, one may predict associated metabolic diseases and determine the prognosis both in pretransplant and posttransplant patients.

Entities:  

Mesh:

Year:  2013        PMID: 23808468     DOI: 10.5858/arpa.2012-0048-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  18 in total

Review 1.  Tissue diagnosis of hepatocellular carcinoma.

Authors:  Deepali Jain
Journal:  J Clin Exp Hepatol       Date:  2014-04-01

Review 2.  Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.

Authors:  Helen L Reeves; Marco Y W Zaki; Christopher P Day
Journal:  Dig Dis Sci       Date:  2016-02-26       Impact factor: 3.199

3.  Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.

Authors:  Wei Song; Jingjing Zhang; Qingxin Xia; Miaomiao Sun
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

4.  Steatohepatitic hepatocellular carcinoma-a case report with literature review.

Authors:  Nalini Gupta; Archana Rastogi; Chhagan Bihari
Journal:  Indian J Surg Oncol       Date:  2014-02-27

Review 5.  The changing landscape of hepatocellular carcinoma: etiology, genetics, and therapy.

Authors:  Erik S Knudsen; Purva Gopal; Amit G Singal
Journal:  Am J Pathol       Date:  2013-12-31       Impact factor: 4.307

6.  MRI features associated with HCC histologic subtypes: a western American and European bicenter study.

Authors:  Sébastien Mulé; Ali Serhal; Athena Galletto Pregliasco; Jessica Nguyen; Camila Lopes Vendrami; Edouard Reizine; Guang-Yu Yang; Julien Calderaro; Giuliana Amaddeo; Alain Luciani; Frank H Miller
Journal:  Eur Radiol       Date:  2022-08-24       Impact factor: 7.034

7.  Familial Hepatocellular Carcinoma- First Reported Case from India.

Authors:  Smita Chandra; Anuradha Kusum; Harish Chandra; Kanika Yadav; Sanjiv Kumar Verma
Journal:  J Clin Diagn Res       Date:  2016-03-01

8.  Clinicopathological indices to predict hepatocellular carcinoma molecular classification.

Authors:  Poh Seng Tan; Shigeki Nakagawa; Nicolas Goossens; Anu Venkatesh; Tiangui Huang; Stephen C Ward; Xiaochen Sun; Won-Min Song; Anna Koh; Claudia Canasto-Chibuque; Manjeet Deshmukh; Venugopalan Nair; Milind Mahajan; Bin Zhang; Maria Isabel Fiel; Masahiro Kobayashi; Hiromitsu Kumada; Yujin Hoshida
Journal:  Liver Int       Date:  2015-06-29       Impact factor: 5.828

Review 9.  Obesity and cancer pathogenesis.

Authors:  Nathan A Berger
Journal:  Ann N Y Acad Sci       Date:  2014-04       Impact factor: 5.691

10.  Risk factors for non-alcoholic fatty liver disease are common in patients with non-B non-C hepatocellular carcinoma in India.

Authors:  Deepu David; Anantharam Raghavendran; Ashish Goel; C Bharath Kumar; Thomas Alex Kodiatte; Deepak Burad; Priya Abraham; Banumathi Ramakrishna; Philip Joseph; Jeyamani Ramachandran; C E Eapen
Journal:  Indian J Gastroenterol       Date:  2017-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.